aTyr Amends Charter for Reverse Stock Split Effect Oct 28 2026
aTyr Pharma filed an amendment to its certificate of incorporation as part of a reverse stock split effective in roughly two years, which consolidates 40 shares of common stock into one. This move is aimed at meeting the continuous listing requirements of The Nasdaq Stock Market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed